[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.169.191. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
April 26, 2000

Preventing Harm From Thimerosal in Vaccines

Author Affiliations
 

Phil B.FontanarosaMD, Deputy EditorIndividualAuthorStephen J.LurieMD, PhD, Contributing EditorIndividualAuthor

JAMA. 2000;283(16):2104-2105. doi:10.1001/jama.283.16.2101

To the Editor: In his editorial regarding thimerosal (a mercury-containing preservative) in vaccines, Dr Halsey1 stated that the Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics should express a preference for thimerosal-free diphtheria-tetanus-acellular pertussis (DTaP) and Haemophilus influenzae type b (Hib) vaccines for infants. Halsey recently championed a similar policy delaying the use of thimerosal-containing hepatitis B vaccine for low-risk infants.1

First Page Preview View Large
First page PDF preview
First page PDF preview
×